When was JenaValve Technology founded?

JenaValve Technology was founded in 2006 and raised its 1st funding round within a year of its incorporation.

Where is JenaValve Technology located?

JenaValve Technology is headquartered in Irvine, United States. It is registered at 4 Cromwell Irvine, CA 92618.

Who is the current CEO of JenaValve Technology?

John Kilcoyne of JenaValve Technology.

Which legal entities is JenaValve Technology associated with?

JenaValve Technology is associated with JenaValve Technology GmbH and 2 others.

How many employees does JenaValve Technology have?

As of Sep 30, 2026, the latest employee count at JenaValve Technology is 257.

Is JenaValve Technology a funded company?

JenaValve Technology is a funded company, having raised a total of $364M across 13 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 22, 2006.

How much is JenaValve Technology worth?

The last known valuation of JenaValve Technology was $***** as of Feb 11, 2025.

When was the latest funding round of JenaValve Technology?

JenaValve Technology's latest funding was a $***** Series C round on Dec 21, 2021, with participation from 11 investors. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.59B in funding in 2026 to date.

Where does JenaValve Technology rank among its competitors?

JenaValve Technology ranks 2nd amongst 115 active competitors, of which 51 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was HighLife Medical, which secured $90M in Sep, 2026.

Who are the top competitors of JenaValve Technology?

JenaValve Technology's top competitors include Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies. Among them, HighLife Medical secured the most recent funding round in September, 2026.

JenaValve Technology - 2026 Company Profile, Team, Funding & Competitors

JenaValve Technology is an acquired company based in Irvine (United States), founded in 2006. It operates as a Provider of pericardial transcatheter aortic valve replacement and delivery system. JenaValve Technology has raised $364M in funding from investors like Sunstone, Gimv and Valiance Asset Management, with last known valuation of $*****. The company has 115 active competitors, including 51 funded and 30 that have exited. Its top competitors include companies like Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies.

Company Details

Provider of pericardial transcatheter aortic valve replacement and delivery system. It offers Trilogy Valve with locator technology that includes a root valve sewn onto a stent and a delivery system for the treatment of aortic valve stenosis for treatment of patients suffering from the aortic valve insufficiency.

Website: jenavalve.com
Social
Registered Address: 4 Cromwell Irvine, CA 92618

Key Metrics

Founded Year

2006

Location

Irvine, United States

Stage

Acquired

Total Funding

$364M in 13 rounds

Latest Funding Round

Series C, Dec 21, 2021, $*****

Last Known Valuation

$***** as on Feb 11, 2025

Investors

Sunstone & 21 more

Ranked

2^nd among 115 active competitors

Employee Count

257 as on Sep 30, 2026

Similar Companies

Cardiac Dimensions & 149 more

Exit Details

Acquired by Edwards Lifesciences (Jul 25, 2024)

View JenaValve Technology's full profile

JenaValve Technology is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Jenavalve Technology, Inc CIN: 4132238 , United States, Active	Mar 26, 2006	-	46 (As on Dec 31, 2020)	-
JenaValve Production Ltd CIN: 09520509 , Belgium, Active	Mar 30, 2015	-	60 (As on Dec 31, 2023)	-
JenaValve Technology GmbH CIN: HRB167207. , Germany, Active	Mar 29, 2007	-	10 (As on Dec 31, 2023)

JenaValve Technology got acquired by Edwards Lifesciences on Jul 25, 2024.

Click here to take a look at JenaValve Technology's acquisition in detail

JenaValve Technology has raised a total funding of $364M over 13 rounds. Its first funding round was on Sep 22, 2006. Its latest funding round was a Series C round on Dec 21, 2021 for $*****. 11 investors participated in its latest round. JenaValve Technology has 22 institutional investors.

Here is the list of recent funding rounds of JenaValve Technology:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 21, 2021	2012761	Series C	7152244	3444971	1665078	8111653
Jan 31, 2020	2759118	Series C	2500420	7670391	2658989	Andera Partners & 6 more
Jun 06, 2019	2246989	Series C	3237483	9890667	3027993	8468206

Access funding benchmarks and valuations. Sign up today!

View details of JenaValve Technology's funding rounds and investors

JenaValve Technology's employee count trend

JenaValve Technology has 257 employees as of Sep 26. Here is JenaValve Technology's employee count trend over the years:

Employee count trend for JenaValve Technology

Uncover JenaValve Technology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of JenaValve Technology include Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies. Here is the list of Top 10 competitors of JenaValve Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cardiac Dimensions 2001, Kirkland (United States), Series E	Developer of invasive cardiac implants for heart failure	$261M	Life Sciences Partners, Lumira Ventures & 20 others	65/100
2nd	JenaValve Technology 2006, Irvine (United States), Acquired	Provider of pericardial transcatheter aortic valve replacement and delivery system	$364M	Bain Capital Life Sciences, Kreos Capital ... & 20 others	64/100
3rd	Pi-Cardia 2009, Rehovot (Israel), Series D	Developer of non-implant device for valve repair	$40M	Clal Biotechnology Industries, Sofinnova Partners ... & 9 others	64/100
4th	Peijia Medical Technologies 2012, Suzhou (China), Public	Developer of medical devices for the treatment of cardiac and cerebrovascular diseases	$110M	Lilly Asia Ventures, SDIC Innovation & 9 others	64/100
5th	MicroPort CardioFlow Medtech Corporation 2015, Pudong (China), Public	Developer of smart medical devices for patients with heart valve diseases	$132M	Lake Bleu Capital, CICC & 10 others	63/100
6th	Shockwave Medical 2009, Santa Clara (United States), Acquired	Developer of cardiovascular balloon dilation catheters	$148M	Sofinnova Partners, Venrock & 9 others	62/100
7th	Venus MedTech 2009, Hangzhou (China), Public	Transcatheter aortic valves	$37M	DCP, DNV Capital & 6 others	62/100
8th	CroiValve 2016, Dublin (Ireland), Series B	Early‑stage medical device company developing a minimally invasive transcatheter system for repairing tricuspid valve regurgitation	$52.1M	Irrus Investments, Halo Business Angel Network ... & 21 others	60/100
9th	HighLife Medical 2010, Paris (France), Series C	Developer of trans-catheter mitral valve replacement system	$141M	Sofinnova Partners, Andera Partners & 15 others	60/100
10th	TRiCares 2013, Aschheim (Germany), Series D	Developer of a minimally invasive tricuspid valve replacement system. This system is designed to treat tricuspid regurgitation, a serious heart condition, without the need for open-heart surgery. The company focuses on developing a safe and effective solution to address the limitations of existing treatment approaches. It is developing a catheter-based system for tricuspid valve replacement. The company's efforts include clinical trials and securing funding to support further development and clinical milestones.	$103M	415 CAPITAL, Lifeblood Capital & 10 others	58/100